global provider of customized laboratory and research services

MSS receives ISO 15189 accreditation

We are pleased to announce that the Mount Sinai Services Inc. (MSS) laboratory has successfully achieved ISO 15189 (OLA15189PLUS™) accreditation. MSS is one of very few independent clinical research laboratories in Canada to achieve this accreditation thereby providing their clients with strong assurance, compliance and added value when submitting for publications and regulatory approvals.

Mount Sinai Services (MSS) is a leading independent clinical research laboratory located at Mount Sinai Hospital with a strong focus on individualized medicine and diagnostics. MSS serves (bio)pharmaceutical, medical device, academic research, hospital and specialty healthcare clients with:

  • Development and validation of unique research assays and diagnostic tools
  • Design and execution of clinical validation studies to support FDA and Health Canada regulatory submissions.
  • Research & clinical trial management including a broad testing menu of more than 2000 routine and esoteric tests.
  • Personalized medicine with specialized expertise in prognostic & diagnostic tools.
  • Diagnostics development from biochemistry laboratory to point-of-care e.g. lab-on-chip

MSS has a global service reach with a network of more than 100 collaborators
(researchers/scientists/clinicians/surgeons…) in different fields. This enables unique access to diverse clinical centres, patients and Key Opinion Leaders across therapeutic specialties. MSS also has expansive and innovative laboratory capabilities.

According to Dr. A. Azad, Managing Director, “The Vision of Mount Sinai Services is to provide customized laboratory and research services using cutting edge technologies, with the highest level of quality to our clients. We are focused on individualized medicine and companion diagnostics. Our mission is to improve patient health by enabling translational medicine and providing Life Science and Healthcare companies with advanced services integral to the development and delivery of new pharmaceutical, device and diagnostic products. MSS also registered with The Centers for Medicare & Medicaid Services (CMS) and expect to acquire the CLIA (Clinical Laboratory Improvement Amendments) accreditation as part of our next milestones very soon.”

Gaman Modi -MSS Quality Team Lead agrees “Having ISO15189 accreditation from IQMH, QMP-LS is a significant step to reinforce our Quality System platform and to show our commitment to quality in all clinical research services we provide. MSS sets a benchmark for clinical research laboratories.”

Leave a Reply